We studied the replication and cytopathicity in SCID-hu mice of R5 human im
munodeficiency virus type 1 (HIV-1) biological clones from early and late s
tages of infection of three patients who never developed MT-2 cell syncytiu
m-inducing (SI; R5X4 or X4) viruses. Several of the late-stage non-MT-2 cel
l syncytium-inducing (NSI; R5) viruses from these patients depleted human C
D4(+) thymocytes from SCID-hu mice. Earlier clones from the same patients d
id not deplete CD4(+) thymocytes from SCID-hu mice as well as later clones.
We studied three R5 HIV-1 clones from patient ACH142 in greater detail. Tw
o of these clones were obtained prior to the onset of AIDS; the third was o
btained following the AIDS diagnosis. In GHOST cell infection assays, all t
hree ACH142 R5 HIV-1 clones could infect GHOST cells expressing CCR5 but no
t GHOST cells expressing any of nine other HIV coreceptors tested. Furtherm
ore, these patient clones efficiently infected stimulated peripheral blood
mononuclear cells from a normal donor but not those from a homozygous CCR5
Delta 32 individual. Statistical analyses of data obtained from infection o
f SCID-hu mice with patient ACH142 R5 clones revealed that only the AIDS-as
sociated clone significantly depleted CD4(+) thymocytes from SCID-hu mice.
This clone also replicated to higher levels in SCID-hu mice than the two ea
rlier clones, and a significant correlation between viral replication and C
D4(+) thymocyte depletion was observed. Our results indicate that an intrin
sic property of AIDS-associated R5 patient clones causes their increased re
plication and cytopathic effects in SCID-hu mice and likely contributes to
the development of AIDS in patients who harbor only R5 quasispecies of HIV-
1.